Skip to main content

Table 4 The influence of individual study on the pooled estimate for outcomes

From: Clinical significance of FBXW7 tumor suppressor gene mutations and expression in human colorectal cancer: a systemic review and meta-analysis

Outcome

Study omitted

HR(95%CI)

I2 (%)

Ph

Z

P value

OS

Chang, 2015 [11]

1.32 (1.15–1.52)

49

0.05

3.93

<  0.01

He, 2019 [13]

1.23 (1.04–1.47)

76

<  0.01

2.38

0.02

Mouradov, 2013 [19]

1.28 (1.08–1.52)

75

<  0.01

2.83

<  0.01

Liu, 2018 [18]

1.22 (1.02–1.47)

74

<  0.01

2.18

0.03

Korphaisarn, 2017 [16]

1.23 (1.02–1.48)

75

<  0.01

2.21

0.03

Iwatsuki, 2010 [14]

1.19 (1.03–1.38)

59

0.01

2.39

0.02

Li, 2018 [17]

1.23 (1.03–1.48)

75

<  0.01

2.24

0.03

Tang, 2016 [24] 

1.26 (1.06–1.48)

76

<  0.01

2.69

<  0.01

Gao, 2019 [12]

1.29 (1.10–1.52)

73

<  0.01

3.10

<  0.01

Kawashita, 2017 [15]

1.24 (1.05–1.47)

76

<  0.01

2.55

0.01

DFS

He, 2019 [13]

1.01 (0.56–1.80)

0

0.80

0.03

0.97

Li, 2018 [17]

1.02 (0.58–1.79)

0

0.82

0.06

0.95

Gao, 2018 [12]

1.31 (0.56–3.11)

0

0.94

0.62

0.53

Kawashita, 2017 [15]

0.99 (0.51–1.91)

0

0.78

0.03

0.98